73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Genetic discovery could improve treatment of colorectal cancer

Genetic discovery could improve treatment of colorectal cancer

by Rémi Carlier,Ecole Polytechnique Federale de LausannePOU5F1B differs from OCT4. a Representative immunofluorescence–confocal microscopy of POU5F1B-HA overexpressing SW480 cells, with DAPI in

Genetic discovery could improve treatment of colorectal cancer

by Rémi Carlier,Ecole Polytechnique Federale de LausannePOU5F1B differs from OCT4. a Representative immunofluorescence–confocal microscopy of POU5F1B-HA overexpressing SW480 cells, with DAPI in
Meta-analysis links high-risk Epstein-Barr virus lineage to nasopharyngeal cancer in southern China

Meta-analysis links high-risk Epstein-Barr virus lineage to nasopharyngeal cancer in southern China

byThe University of Hong KongPhylogenetic and population structure analysis. Credit:PLOS Pathogens(2024). DOI: 10.1371/journal.ppat.1012263Researchers at the LKS Faculty of Medicine

Meta-analysis links high-risk Epstein-Barr virus lineage to nasopharyngeal cancer in southern China

byThe University of Hong KongPhylogenetic and population structure analysis. Credit:PLOS Pathogens(2024). DOI: 10.1371/journal.ppat.1012263Researchers at the LKS Faculty of Medicine
Mitochondrial protein synthesis identified as a potential therapeutic target in lymphoma

Mitochondrial protein synthesis identified as a potential therapeutic target in lymphoma

byUniversity of OxfordSpleen sections from mito-QC mice immunized with SRBC and analyzed on day 12. Scale bar, 50 μm. Representative of three independent experiments. Credit:Nature Immunol

Mitochondrial protein synthesis identified as a potential therapeutic target in lymphoma

byUniversity of OxfordSpleen sections from mito-QC mice immunized with SRBC and analyzed on day 12. Scale bar, 50 μm. Representative of three independent experiments. Credit:Nature Immunol
How sweet it isn't: Diminished taste function affects cancer patients' food intake

How sweet it isn't: Diminished taste function affects cancer patients' food intake

by Alissa Nolden,University of Massachusetts AmherstAlissa Nolden is an assistant professor of food science at UMass Amherst. Credit: UMass AmherstThe simple pleasure of tasting and savoring foo

How sweet it isn't: Diminished taste function affects cancer patients' food intake

by Alissa Nolden,University of Massachusetts AmherstAlissa Nolden is an assistant professor of food science at UMass Amherst. Credit: UMass AmherstThe simple pleasure of tasting and savoring foo
Treat cancer with cold plasma? Aerospace engineer helps bring first clinical trial

Treat cancer with cold plasma? Aerospace engineer helps bring first clinical trial

by Kayla Wiles,Purdue UniversityPurdue aerospace engineer Alexey Shashurin assisted in the development of the Canady Helios Cold Plasma System and Scalpel, which has been approved by the FDA for

Treat cancer with cold plasma? Aerospace engineer helps bring first clinical trial

by Kayla Wiles,Purdue UniversityPurdue aerospace engineer Alexey Shashurin assisted in the development of the Canady Helios Cold Plasma System and Scalpel, which has been approved by the FDA for
New Co-STAR T cells show promise for treating cancers in laboratory study

New Co-STAR T cells show promise for treating cancers in laboratory study

byJohns Hopkins University School of MedicineNew cell type, called Co-STAR, fights cancer cells. Credit: Elizabeth CookUsing genetic engineering techniques, investigators at the Johns Hopkins Ki

New Co-STAR T cells show promise for treating cancers in laboratory study

byJohns Hopkins University School of MedicineNew cell type, called Co-STAR, fights cancer cells. Credit: Elizabeth CookUsing genetic engineering techniques, investigators at the Johns Hopkins Ki
Researchers develop new CRISPR-based tool for cancer diagnosis

Researchers develop new CRISPR-based tool for cancer diagnosis

by Leah Buletti,University of FloridaThe one-pot EXTRA-CRISPR miRNA assay. Credit:Nature Biomedical Engineering(2023). DOI: 10.1038/s41551-023-01033-1A team of University of Florida

Researchers develop new CRISPR-based tool for cancer diagnosis

by Leah Buletti,University of FloridaThe one-pot EXTRA-CRISPR miRNA assay. Credit:Nature Biomedical Engineering(2023). DOI: 10.1038/s41551-023-01033-1A team of University of Florida
'Natural killers' may help treat advanced solid cancerous tumors

'Natural killers' may help treat advanced solid cancerous tumors

by Chris Adam,Purdue UniversityCredit: Purdue UniversityAn internal battle over oxygen can lead to major setbacks for people battling solid malignant tumors such as lung and brain cancers. Many

'Natural killers' may help treat advanced solid cancerous tumors

by Chris Adam,Purdue UniversityCredit: Purdue UniversityAn internal battle over oxygen can lead to major setbacks for people battling solid malignant tumors such as lung and brain cancers. Many
Surge in syphilis cases leads some providers to ration penicillin

Surge in syphilis cases leads some providers to ration penicillin

by Catherine Sweeney, WPLN, KFF Health NewsCredit: Pixabay/CC0 Public DomainWhen Stephen Miller left his primary care practice to work in public health a little under two years ago, he said, he was sh

Surge in syphilis cases leads some providers to ration penicillin

by Catherine Sweeney, WPLN, KFF Health NewsCredit: Pixabay/CC0 Public DomainWhen Stephen Miller left his primary care practice to work in public health a little under two years ago, he said, he was sh
Severe mental illness linked to low attendance at cancer screening

Severe mental illness linked to low attendance at cancer screening

byUniversity of SurreyCredit: CC0 Public DomainPeople with severe mental illness are less likely to attend cancer screening compared to those who do not have such conditions, according to new re

Severe mental illness linked to low attendance at cancer screening

byUniversity of SurreyCredit: CC0 Public DomainPeople with severe mental illness are less likely to attend cancer screening compared to those who do not have such conditions, according to new re
Existing drug shows promise treating most prevalent type of lung cancer

Existing drug shows promise treating most prevalent type of lung cancer

byUniversity of KentuckyCZT binds to SRC. A. CZT binding (dashed circle) to SRC. CZT binds near the C-terminal domain of SRC and may disrupt the inactive state by preventing phosphorylation on t

Existing drug shows promise treating most prevalent type of lung cancer

byUniversity of KentuckyCZT binds to SRC. A. CZT binding (dashed circle) to SRC. CZT binds near the C-terminal domain of SRC and may disrupt the inactive state by preventing phosphorylation on t
Nirogacestat, a new desmoid tumor treatment, found to improve outcomes for people with sarcoma

Nirogacestat, a new desmoid tumor treatment, found to improve outcomes for people with sarcoma

byMemorial Sloan Kettering Cancer CenterCredit:New England Journal of Medicine(2023). DOI: 10.1056/NEJMoa2210140When Dana Avellino, now 36, first noticed a lump near her groin in the

Nirogacestat, a new desmoid tumor treatment, found to improve outcomes for people with sarcoma

byMemorial Sloan Kettering Cancer CenterCredit:New England Journal of Medicine(2023). DOI: 10.1056/NEJMoa2210140When Dana Avellino, now 36, first noticed a lump near her groin in the